---
document_datetime: 2023-09-21 18:16:34
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/topotecan-hospira-epar-all-authorised-presentations_en.pdf
document_name: topotecan-hospira-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7893151
conversion_datetime: 2025-12-24 00:44:38.950026
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Name              | Strength   | Pharmaceutical Form                   | Route of Administration   | Packaging    | Content   | Package size   |
|-----------------|-------------------|------------|---------------------------------------|---------------------------|--------------|-----------|----------------|
| EU/1/10/633/001 | Topotecan Hospira | 4 mg/4 ml  | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 4 ml      | 1 vial         |
| EU/1/10/633/002 | Topotecan Hospira | 4 mg/4 ml  | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 4 ml      | 5 vials        |